Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide adjunctive therapy in pediatric partial-onset seizures
2012-004996-38Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy and Focal Onset Epilepsy comparing Lacosamide adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Change in partial-onset seizure frequency per 28 days. Started Aug 2013; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on 2012-004996-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004996-38.